Provider Information

Over 11 years ago, Florida Accountable Care Services (FACS) began its value-driven journey fueled by the desire to create opportunities that preserve and support the independence and sustainability of community-based providers, and positively impact the delivery and outcomes of healthcare through the implementation of innovative value-based programs. Together with our Guardian Teams, and in no small part, the dedication and commitment of our ACO providers, we have successfully generated $150 Million Dollars in shared savings, positively affected the lives of over one million patients, and delivered multiple programs and service delivery platforms to our ACO Practices which have consistently increased their individual profitability and the quality of care delivered to patients.

In further pursuit of our mission we have established a clinical trials company, Guardian Research Organization (GRO, LLC that is committed to creating a clinical trials center of excellence that provides FACS primary care and affiliated specialist providers opportunities to participate and receive financial remuneration in clinical research trials funded by some of the most reputable pharmaceutical, biotechnology, and medical device companies in the world.

Our focused therapeutic areas for clinical trials include:

• Cardiology
• Endocrinology
• Gastroenterology
• Infectious Disease
• Nephrology
• Neurology
• Pulmonology
• Rheumatology

We invite you to formally participate in this endeavor dedicated to transforming practiced based scientific clinical research into effective treatments for the vexing diseases and conditions that impact your patient population. You may participate as a:

Collaborator – Serving as a referral source for patients under your care who may benefit from clinical
trials directed by GRO.

Contributor – Serving as a Principal Investigator (PI) or Sub-Investigator (Sub-I) for one or more clinical
trials.

Conductor – Leveraging your existing research experience as a principal investigator to bring clinical trials
directly to your practice with support from GRO.

Your participation with GRO will, at a minimum, provide you and your practice opportunities to:

• Diversification of practice revenue and increased financial performance.
• Opportunity to provide your patients facing life-threatening diseases access to potentially life-changing and cutting edge therapies not otherwise available outside of a clinical trial.
• Improved patient satisfaction and patient engagement resulting from the systematic trial-based monitoring.
• Gain advanced access to new and exciting therapeutic and biotechnical interventions under testing by major pharmaceutical, biotechnology, medical device companies in the world.
• Expanded opportunities for enhanced collaboration with peers, and the broader medical
community.
• Enhanced medical reputation and opportunities for publication and presentation at formal
gatherings of peers.
• Provide an avenue for you to establish your mark in the advancement of medical knowledge.

To date we have secured a number of advanced clinical trials that many of your peers are participating in. Moreover, each day new opportunities emerge. If you or your colleagues are interested in participating in cutting edge medical research as well as providing opportunities to your patients to benefit from promising new therapies, then please take the time to complete the interactive GUARDIAN RESEARCH PHYSICIAN INTEREST FORM contained in this section of the website.

Respectfully expressed,

Shayla Bajaj
GRO President & CEO